Acute Dyspnoea in Cancer Patients: Prevalence of Acute Heart Failure, Resource Use and Diagnostic Accuracy of Natriuretic Peptides
European Journal of Heart Failure · 2025
DOI: 10.1002/ejhf.3752 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, 2025. Verfasst von Paolo Bima und 20 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Dyspnea, Heart Failure, Neoplasms, Natriuretic Peptide, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Schweizerische Herzstiftung.
Themen: Onkologische Pflege, Herzinsuffizienz
Abstract (Originalsprache)
Aims
Among cancer patients presenting with acute dyspnoea, the prevalence of acute heart failure (AHF), resource use and diagnostic accuracy of natriuretic peptides remain unknown. This study aimed to address these knowledge gaps. Methods and results Patients presenting with acute dyspnoea to the emergency department (ED) were prospectively enrolled in a multicentre diagnostic study. AHF was centrally adjudicated by two independent cardiologists based on current guidelines. B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) concentrations were measured at ED presentation. Cancer status, resource use, and long-term outcomes were prospectively assessed. Among 2153 patients, 473 (22.0%) had an active or past cancer. AHF was the most common final diagnosis in both cancer and non-cancer patients (44.4% vs. 51.0%, p = 0.01). Among the alternative diagnoses, pneumonia and cancer-related dyspnoea were more frequent in patients with cancer, while anxiety disorder/hyperventilation was frequent in patients without cancer. Hospitalization rate and length of hospital stay were both higher in cancer patients (p < 0.01). Among AHF-related signs, rales and pleural effusion showed a significant interaction with cancer status and had lower diagnostic accuracy in cancer patients. The area under the curve (AUC) of NT-proBNP was lower in cancer than in non-cancer patients (0.89 vs. 0.93, p = 0.01), while that of BNP was similar (0.93 vs. 0.95, p = ns). This difference was mainly due to active cancers.
Conclusions
Acute heart failure was the most common diagnosis in cancer patients presenting with acute dyspnoea. Rales, pleural effusion, and NT-proBNP had lower diagnostic accuracy versus patients without cancer, while that of BNP remained robust.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.
- Department of Medical Sciences, University of Torino, Turin, Italy.
- Department of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, Canada.
- Department of Hematology, University Hospital Basel, Basel, Switzerland.
- Department of Endocrinology and Clinical Nutrition, University Hospital Zürich, Zürich, Switzerland.
- Division of Internal Medicine, University Psychiatry Clinic Zurich, Zurich, Switzerland.
ORCID-Profile: Paolo Bima
Förderung
- Schweizerische Herzstiftung
Zitieren
APA
Bima, P., Wussler, D., Lopez-Ayala, P., Belkin, M., Nowak, A., Lin, X., Strebel, I., Sgueglia, F., Michou, E., Papachristou, A., Chollet, L., Popescu, C., Kozhuharov, N., Shrestha, S., Kuster, G., Rentsch, K., Von Eckardstein, A., Binder, M., Mahfoud, F., …, & Mueller, C. (2025). Acute Dyspnoea in Cancer Patients: Prevalence of Acute Heart Failure, Resource Use and Diagnostic Accuracy of Natriuretic Peptides. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3752
Vancouver
Bima P, Wussler D, Lopez-Ayala P, Belkin M, Nowak A, Lin X, et al. Acute Dyspnoea in Cancer Patients: Prevalence of Acute Heart Failure, Resource Use and Diagnostic Accuracy of Natriuretic Peptides. European Journal of Heart Failure. 2025. doi:10.1002/ejhf.3752
BibTeX
@article{Bima2025,
author = {Bima, Paolo and Wussler, Desirée and Lopez-Ayala, Pedro and Belkin, Maria and Nowak, Albina and Lin, Xueting and Strebel, Ivo and Sgueglia, Fabiana and Michou, Eleni and Papachristou, Androniki and Chollet, Laureve and Popescu, Codruta and Kozhuharov, Nikola and Shrestha, Samyut and Kuster, Gabriela and Rentsch, Katharina and Von Eckardstein, Arnold and Binder, Mascha and Mahfoud, Felix and Breidthardt, Tobias and Mueller, Christian},
title = {Acute Dyspnoea in Cancer Patients: Prevalence of Acute Heart Failure, Resource Use and Diagnostic Accuracy of Natriuretic Peptides},
journal = {European Journal of Heart Failure},
year = {2025},
doi = {10.1002/ejhf.3752}
}
EUVIMED